# NEONC TECHNOLOGIES HOLDINGS INC.: Developing a Clinically Relevant Radiosensitizer for Temozolomide-resistant Gliomas

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | NEONC TECHNOLOGIES HOLDINGS INC. |
| Location | CALABASAS, CA |
| Project | Developing a Clinically Relevant Radiosensitizer for Temozolomide-resistant Gliomas |
| Project number | 5R42CA246902-04 |
| Mechanism | R42 |
| Institute | National Cancer Institute |
| Award | $1,033,906 |
| Awarded | 2026-09-14 |
| Project period | 2020-04-01 to 2027-08-31 |
| UEI | XLZVF5LX5JM8 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11420575). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.